TABLE OF CONTENTS
|  | | | | Volume 53, Issue 1 (January 2018) |  | In this issue
 Editorial
Reviews
Special Report
Original Articles
Letters to the Editor
Also new
   AOP
| | | | Editorial | Top | | Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation N Kröger, M Bishop, S Giralt and A Wayne Bone Marrow Transplant 2018 53: 1-2; advance online publication, October 9, 2017; 10.1038/bmt.2017.218 Full Text | | Reviews | Top | | Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment? A Hegde and H S Murthy Bone Marrow Transplant 2018 53: 3-10; advance online publication, October 30, 2017; 10.1038/bmt.2017.192 Abstract | Full Text | | Post-autologous transplant maintenance therapies in lymphoma: current state and future directions P A Riedell and M R Bishop Bone Marrow Transplant 2018 53: 11-21; advance online publication, October 2, 2017; 10.1038/bmt.2017.196 Abstract | Full Text | | Special Report | Top | | Is there any role for physical therapy in chronic GvHD? J Mohammed, B N Savani, A El-Jawahri, J Vanderklish, A L Cheville and S K Hashmi Bone Marrow Transplant 2018 53: 22-28; advance online publication, August 7, 2017; 10.1038/bmt.2017.155 Abstract | Full Text | | Original Articles | Top | | LYMPHOMA | Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma E Joffe, D Rosenberg, U Rozovski, C Perry, I Kirgner, S Trestman, O Gur, F Aviv, N Sarid, A Kolomansky, L Gepstein, Y Herishanu and E Naparstek Bone Marrow Transplant 2018 53: 29-33; advance online publication, October 16, 2017; 10.1038/bmt.2017.205 Abstract | Full Text | | PLASMA CELL DISORDERS | High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma D Sivaraj, W Bacon, G D Long, D A Rizzieri, M E Horwitz, K M Sullivan, Y Kang, Z Li, N J Chao and C Gasparetto Bone Marrow Transplant 2018 53: 34-38; advance online publication, October 30, 2017; 10.1038/bmt.2017.208 Abstract | Full Text | | INHERITED AND GENETIC DISORDERS | Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major S Santarone, A Pepe, A Meloni, A Natale, L Pistoia, P Olioso, G Papalinetti, L Cuccia, A Spasiano, R Lisi, M Di Ianni, T Bonfini, P Accorsi, S Salvadori, F Papola, S Angelini and P Di Bartolomeo Bone Marrow Transplant 2018 53: 39-43; advance online publication, October 9, 2017; 10.1038/bmt.2017.214 Abstract | Full Text | | CONDITIONING | Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation K Yoshimura, I Yano, T Yamamoto, M Kawanishi, Y Isomoto, A Yonezawa, T Kondo, A Takaori-Kondo and K Matsubara Bone Marrow Transplant 2018 53: 44-51; advance online publication, October 9, 2017; 10.1038/bmt.2017.213 Abstract | Full Text | | SUPPORTIVE CARE | Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation F Farowski, V Bücker, J J Vehreschild, L Biehl, R Cruz-Aguilar, C Scheid, U Holtick, N Jazmati, H Wisplinghoff, O A Cornely and M J G T Vehreschild Bone Marrow Transplant 2018 53: 52-57; advance online publication, November 13, 2017; 10.1038/bmt.2017.203 Abstract | Full Text | | GRAFT-VERSUS-HOST DISEASE | ‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) L Giaccone, G Mancini, N Mordini, G Gargiulo, V De Cecco, S Angelini, M Arpinati, D Baronciani, V Bozzoli, S Bramanti, E Calore, I M Cavattoni, M Cimminiello, A A Colombo, L Facchini, S Falcioni, M Faraci, R Fedele, S Guidi, A P Iori, S Marotta, M C Micò, G Milone, F Onida, D Pastore, F Patriarca, M Pini, R Raimondi, A Rovelli, S Santarone, A Severino, C Skert, M T L Stanghellini, C Tecchio, E Vassallo, M Chiarucci, B Bruno, F Bonifazi and A Olivieri Bone Marrow Transplant 2018 53: 58-63; advance online publication, October 30, 2017; 10.1038/bmt.2017.223 Abstract | Full Text | | Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402 L M Turcotte, T E DeFor, L F Newell, C S Cutler, M R Verneris, J Wu, A Howard, M L MacMillan, J H Antin, G M Vercellotti, Ane Slungaard, B R Blazar, D J Weisdorf, A Panoskaltsis-Mortari and S G Holtan Bone Marrow Transplant 2018 53: 64-68; advance online publication, October 23, 2017; 10.1038/bmt.2017.236 Abstract | Full Text | | IMMUNE RECOVERY | Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients A Gaballa, A Norberg, A Stikvoort, J Mattsson, B Sundberg, M Uzunel, M Remberger and M Uhlin Bone Marrow Transplant 2018 53: 69-77; advance online publication, October 9, 2017; 10.1038/bmt.2017.216 Abstract | Full Text | | INFECTIONS | Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study D Shanis, P Anandi, C Grant, A Bachi, N Vyas, M A Merideth, P A Pophali, E Koklanaris, S Ito, B N Savani, A J Barrett, M Battiwalla and P Stratton Bone Marrow Transplant 2018 53: 78-83; advance online publication, October 16, 2017; 10.1038/bmt.2017.210 Abstract | Full Text | | QOL AND PATIENTS' CARE | Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life J M Snaman, A C Talleur, J Lu, D R Levine, E C Kaye, A Sykes, Z Lu, B M Triplett and J N Baker Bone Marrow Transplant 2018 53: 84-90; advance online publication, November 13, 2017; 10.1038/bmt.2017.187 Abstract | Full Text | | Letters to the Editor | Top | | Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation P Galieni, E Troiani, C Bigazzi, S Mazzotta, M Ruggieri, V Pezzoni, A Dalsass, F Mestichelli, P Caraffa, F Travaglini, S Ferretti, M Angelini, S Angelini and S Falcioni Bone Marrow Transplant 2018 53: 91-93; advance online publication, October 2, 2017; 10.1038/bmt.2017.206 Full Text | | Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome V Wais, L Kündgen, S R Bohl, S von Harsdorf, R F Schlenk, K Döhner, V Teleanu, L Bullinger, T M Nguyen, K Drognitz, J-C Moulin, M Binnenhei, M Bentz, H Döhner, D Bunjes, F Kuchenbauer and M Ringhoffer Bone Marrow Transplant 2018 53: 94-96; advance online publication, November 13, 2017; 10.1038/bmt.2017.211 Full Text | | Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation C Ustun, C Brunstein, T DeFor, A Rashidi, S Yohe, N Bejanyan, S Cooley, E Warlick, J Miller, M A Linden and D Weisdorf Bone Marrow Transplant 2018 53: 97-100; advance online publication, October 9, 2017; 10.1038/bmt.2017.212 Full Text | | Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome P G Hemmati, K Pfeifer, L G Vuong, C F Jehn, T H Terwey, P le Coutre, B Dörken and R Arnold Bone Marrow Transplant 2018 53: 101-103; advance online publication, October 9, 2017; 10.1038/bmt.2017.215 Full Text | | Engender trust and edify A D'Souza, R Spellecy and A Derse Bone Marrow Transplant 2018 53: 104; advance online publication, October 16, 2017; 10.1038/bmt.2017.217 Full Text | | Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis S Pagliuca, A M Risitano, F S De Fontbrune, M Robin, A P Iori, S Marotta, D Michonneau, A Villate, D Desmier, G Socié and R P De Latour Bone Marrow Transplant 2018 53: 105-107; advance online publication, November 13, 2017; 10.1038/bmt.2017.220 Full Text | | Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts L-Q Cao, L Liu, L-P Xu, X-H Zhang, Y Wang, Q-Z Fan, Y-R Liu, K-Y Liu, X-J Huang and Y-J Chang Bone Marrow Transplant 2018 53: 108-110; advance online publication, October 23, 2017; 10.1038/bmt.2017.224 Full Text | | |  | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment